Haopeng Sun

8.5k total citations · 2 hit papers
268 papers, 6.8k citations indexed

About

Haopeng Sun is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Haopeng Sun has authored 268 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Molecular Biology, 81 papers in Pharmacology and 71 papers in Organic Chemistry. Recurrent topics in Haopeng Sun's work include Cholinesterase and Neurodegenerative Diseases (61 papers), Computational Drug Discovery Methods (53 papers) and Alzheimer's disease research and treatments (19 papers). Haopeng Sun is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (61 papers), Computational Drug Discovery Methods (53 papers) and Alzheimer's disease research and treatments (19 papers). Haopeng Sun collaborates with scholars based in China, United States and Germany. Haopeng Sun's co-authors include Feng Feng, Wenyuan Liu, Qidong You, Qi Li, Wei Qu, Yao Chen, Xueyang Jiang, Hongyu Yang, Yao Chen and Siyu He and has published in prestigious journals such as Angewandte Chemie International Edition, Applied Physics Letters and PLoS ONE.

In The Last Decade

Haopeng Sun

256 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The recent progress of isoxazole in medicinal chemistry

2018 306 citations Haopeng Sun et al. Bioorganic & Medicinal Chemistry profile →
Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application

2024 65 citations Shuaishuai Xing, Lei Wang et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haopeng Sun China	42	3.1k	2.2k	1.9k	1.3k	712	268	6.8k
Stefano Alcaro Italy	52	3.7k 1.2×	3.3k 1.5×	1.9k 1.0×	993 0.8×	491 0.7×	300	8.4k
Giuseppe Campiani Italy	42	2.8k 0.9×	2.5k 1.1×	1.3k 0.7×	912 0.7×	510 0.7×	234	6.1k
Giulio Rastelli Italy	36	4.2k 1.3×	2.0k 0.9×	851 0.5×	2.1k 1.6×	703 1.0×	142	7.5k
Maurizio Recanatini Italy	50	3.5k 1.1×	2.3k 1.1×	2.7k 1.4×	2.8k 2.1×	410 0.6×	168	7.9k
Gerhard Wolber Germany	42	4.5k 1.4×	1.8k 0.8×	1.1k 0.6×	2.7k 2.1×	744 1.0×	218	8.0k
Tiziano Tuccinardi Italy	44	3.5k 1.1×	1.4k 0.6×	1.2k 0.6×	815 0.6×	824 1.2×	225	7.0k
Asimul Islam India	46	4.4k 1.4×	741 0.3×	730 0.4×	1.2k 0.9×	676 0.9×	316	7.7k
Jeremy R. Greenwood United States	27	6.8k 2.2×	2.9k 1.3×	1.2k 0.6×	3.2k 2.5×	1.2k 1.7×	67	12.1k
Angelo Carotti Italy	47	2.3k 0.7×	3.3k 1.5×	2.1k 1.1×	1.6k 1.2×	382 0.5×	196	7.2k
Stefano Moro Italy	56	7.4k 2.3×	3.6k 1.6×	745 0.4×	1.8k 1.4×	1.2k 1.7×	354	12.7k

Countries citing papers authored by Haopeng Sun

Since Specialization

Citations

This map shows the geographic impact of Haopeng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haopeng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haopeng Sun more than expected).

Fields of papers citing papers by Haopeng Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haopeng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haopeng Sun. The network helps show where Haopeng Sun may publish in the future.

Co-authorship network of co-authors of Haopeng Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Haopeng Sun. A scholar is included among the top collaborators of Haopeng Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haopeng Sun. Haopeng Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wang, Dawei, Wenjian Min, Baichuan Jiang, et al.. (2025). From concept to application: Exploring the evolution and potential of DUBTAC technology. Acta Pharmaceutica Sinica B. 16(2). 770–787.

2.

Sun, Tian‐Yu, et al.. (2025). Brief analysis of Nav1.7 inhibitors: Mechanism of action and new research trends. Bioorganic & Medicinal Chemistry. 128. 118180–118180.

3.

Xi, Meiyang, Jingjing Zhu, Fengxia Zhang, et al.. (2024). Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads. European Journal of Medicinal Chemistry. 276. 116709–116709. 22 indexed citations

4.

Zhen, Tao, Tianyu Sun, Bin Xiong, et al.. (2024). New insight into targeting the DNA damage response in the treatment of glioblastoma. Chinese Journal of Natural Medicines. 22(10). 869–886. 2 indexed citations

5.

Wei, Yuqing, Huajing Yang, Xueqing Wang, et al.. (2024). Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies. European Journal of Medicinal Chemistry. 272. 116496–116496. 5 indexed citations

6.

Zhu, Jiawei, Yucheng Xiong, Xiaoxue Bai, et al.. (2024). Small molecule-drug conjugates: Mechanistic insights and strategic design for enhanced cancer therapy. Chinese Chemical Letters. 36(10). 110799–110799.

7.

Xing, Shuaishuai, Zhiqiang Wang, Ao Zhang, et al.. (2024). NRF2 inhibitors: Recent progress, future design and therapeutic potential. European Journal of Medicinal Chemistry. 279. 116822–116822. 12 indexed citations

8.

Sun, Tian‐Yu, et al.. (2024). New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands. European Journal of Medicinal Chemistry. 275. 116569–116569. 28 indexed citations

9.

Sun, Tianyu, et al.. (2024). Advances in design strategies and imaging applications of specific butyrylcholinesterase probes. Chinese Chemical Letters. 36(7). 110451–110451. 3 indexed citations

10.

Sun, Chengliang, Yuling He, Gefei Wang, et al.. (2024). Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors. Journal of Medicinal Chemistry. 67(5). 3590–3605. 13 indexed citations

11.

Chen, Tingkai, Zhenqi Wang, Feng Feng, et al.. (2023). Inhibition of Son of Sevenless Homologue 1 (SOS1): Promising therapeutic treatment for KRAS-mutant cancers. European Journal of Medicinal Chemistry. 261. 115828–115828. 9 indexed citations

12.

Liu, Chang, Weiping Lyu, Jian Xu, et al.. (2023). Discovery of thiazole salt AChE inhibitors and development of thiamine disulfide prodrugs targeting the central nervous system. Bioorganic Chemistry. 139. 106702–106702. 6 indexed citations

13.

Zhu, Yasheng, Hao Shen, Hongtao Shen, et al.. (2023). Discovery of Potent and Wild-Type-Sparing Fourth-Generation EGFR Inhibitors for Treatment of Osimertinib-Resistance NSCLC. Journal of Medicinal Chemistry. 66(10). 6849–6868. 22 indexed citations

14.

Chen, Long, et al.. (2023). Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer’s Disease Neurodegeneration. Cells. 12(23). 2672–2672. 13 indexed citations

15.

Pan, Di, et al.. (2022). AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma. Oncogene. 41(31). 3846–3858. 19 indexed citations

16.

Song, Zhiqiang, Yingjie Wang, Peng Xu, et al.. (2022). Direct Synthesis of 2,6‐Dideoxy‐β‐glycosides and β‐Rhamnosides with a Stereodirecting 2‐(Diphenylphosphinoyl)acetyl Group. Angewandte Chemie International Edition. 61(33). e202206128–e202206128. 24 indexed citations

17.

Song, Zhiqiang, Yingjie Wang, Peng Xu, et al.. (2022). Direct Synthesis of 2,6‐Dideoxy‐β‐glycosides and β‐Rhamnosides with a Stereodirecting 2‐(Diphenylphosphinoyl)acetyl Group. Angewandte Chemie. 134(33). 1 indexed citations

18.

Song, Yingying, Ao Liu, Huiyong Sun, et al.. (2022). More than a Leaving Group: N‐Phenyltrifluoroacetimidate as a Remote Directing Group for Highly α‐Selective 1,2‐cis Glycosylation. Angewandte Chemie. 134(21). 2 indexed citations

19.

Song, Yingying, Ao Liu, Huiyong Sun, et al.. (2022). More than a Leaving Group: N‐Phenyltrifluoroacetimidate as a Remote Directing Group for Highly α‐Selective 1,2‐cis Glycosylation. Angewandte Chemie International Edition. 61(21). e202201510–e202201510. 21 indexed citations

20.

Jiang, Hongli, Lei Chen, Jian Xu, et al.. (2019). Design, synthesis and evaluation of wound healing activity for β-sitosterols derivatives as potent Na+/K+-ATPase inhibitors. Bioorganic Chemistry. 98. 103150–103150. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact